Last $1.36 USD
Change Today +0.07 / 5.43%
Volume 556.3K
ATHX On Other Exchanges
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John J. Harrington Ph.D.

Co-Founder, Chief Scientific Officer, Executive Vice President and Director, Athersys, Inc.
AgeTotal Calculated CompensationThis person is connected to 24 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. John J. Harrington, Ph.D. co-founded Athersys, Inc. in October 1995 and has been its Executive Vice President and Chief Scientific Officer since October 1995. Dr. Harrington is a Co-developer of the SMC technology, and has led the development of the RAGE technology for both gene discovery and commercial protein production applications. He has been a Director at Athersys, Inc. since June 2007. From 1994 to 1998, he had a research appointment at Case Western Reserve ...

Read Full Background

Corporate Headquarters*

3201 Carnegie Avenue
Cleveland, Ohio 44115

United States

Phone: 216-431-9900
Fax: 216-361-9495

Board Members Memberships*

Co-Founder, Chief Scientific Officer, Executive Vice President and Director


The Leland Stanford Junior University
University of California - San Diego

Other Affiliations*

Annual Compensation*

Total Annual Compensation$452,900

Stock Options*

Restricted Stock Awards$975,642
All Other Compensation$4,355
Exercisable Options735,000
Unexercisable Options87,500
Total Number of Options822,500

Total Compensation*

Total Annual Cash Compensation$457,255
Total Short Term Compensation$452,900
Other Long Term Compensation$979,997
Total Calculated Compensation$1,575,897
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATHX:US $1.36 USD +0.07


Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERSYS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at